Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Attaei, Marjan; Khatib, Rasha; McKee, Martin; Lear, Scott; Dagenais, Gilles; Igumbor, Ehimario; AlHabib, Khalid; Kaur, Manmeet; Kruger, Lanthe; Teo, Koon; Lanas, Fernando; Yusoff, Khalid; Oguz, AYTEKİN; Gupta, Rajeev; Yusufali, Afzalhussein; Bahonar, Ahmad; Kutty, Raman; Rosengren, Annika; Mohan, Viswanathan; Avezum, Alvaro; Yusuf, Rita; Szuba, Andrzej; Rangarajan, Sumathy; Chow, Clara; Yusuf, Salim

Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Atıf İçin Kopyala

Attaei M. W. , Khatib R., McKee M., Lear S., Dagenais G., Igumbor E. U. , et al.

LANCET PUBLIC HEALTH, cilt.2, 2017 (SCI İndekslerine Giren Dergi)

Cilt numarası: 2 Konu: 9
Basım Tarihi: 2017
Dergi Adı: LANCET PUBLIC HEALTH

Özet

Background Hypertension is considered the most important risk factor for cardiovascular diseases, but its control is poor worldwide. We aimed to assess the availability and affordability of blood pressure-lowering medicines, and the association with use of these medicines and blood pressure control in countries at varying levels of economic development.